About ProstateNext:

ProstateNext is a genetic test that provides your healthcare providers with the tools necessary to manage and identify your risk for hereditary prostate cancer. The test looks at 14 different genes, including BRCA1 and BRCA2 (known as breast cancer predisposition genes). These genes, when mutated, have been shown to be associated with a 15% lifetime risk of developing prostate cancer, which is significantly higher than average risk men without the mutation.  

The results of the ProstateNext text can help your healthcare provider determine your hereditary cancer risk, and along with other risk factors and PCMs, can aid in the development of  a customized monitoring or diagnostic plan based upon your results. 

Patient Resources:

Below are several resources designed to help patients and their family better understand how ProstateNext is used in a clinical setting, including a video as well as downloadable brochures. 

PCMs Brochure

This brochure, designed by pcmarkers.com, will help patients and their family further understand the test. 

ProstateNext Brochure

This brochure, designed by Ambry Genetics, will help patients and their family further understand the test. 

ProstateNext Sample Report

This sample report will help patients and their families understand how the results for this test are presented. 

What is My Risk?

This questionnaire will help patients (with the help of their healthcare provider) determine their risk for hereditary cancers.

Aurora, Colorado | Info@pcmarkers.com